Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION

v3.25.3
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2025
SEGMENT INFORMATION  
SEGMENT INFORMATION

13.Segment Information

We view our operations and manage our business as one operating segment, and our chief operating decision maker (CODM) is our chief executive officer. The following table presents segment information for the periods presented:

Three Months Ended September 30, 

Nine Months Ended September 30, 

2025

2024

 

2025

2024

(in thousands)

(in thousands)

Total Revenues

$

69,462

$

55,307

$

224,480

$

121,682

Less:

Employee related expenses

18,547

16,104

56,666

52,552

Commercial related expenses

6,303

6,768

18,915

19,002

Outside clinical trial related expenses

3,759

3,303

11,362

8,183

Cost of product sales

4,753

8,026

13,666

12,859

Consultants and third-party services

4,133

3,476

10,751

11,851

Other segment items

3,547

3,574

10,824

9,698

Interest expense, net

800

1,635

3,183

4,393

(Benefit from) provision for income taxes

(280)

154

Segment income

$

27,900

$

12,421

$

98,959

$

3,144

There is no reconciling items or adjustments between segment income presented above and net income as presented in our statements of operations. The CODM does not review assets in evaluating the segment results and therefore such information is not presented.

For details of revenues disaggregated by category, see “Note 3 – Revenues.”

Employee related expenses primarily comprised salaries, employee benefits, other employee related expenses and stock-based compensation expense. For details of stock-based compensation expense, see “Note 6 – Stock-Based Compensation.” Other segment items for the periods presented primarily comprised travel related expenses, business insurance, taxes and licenses, and facility related expenses.